KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Medpace Holdings (MEDP) Shares Repurchased (2017 - 2025)

Medpace Holdings filings provide 7 years of Shares Repurchased readings, the most recent being $4.5 million for Q3 2025.

  • On a quarterly basis, Shares Repurchased changed N/A to $4.5 million in Q3 2025 year-over-year; TTM through Mar 2026 was $523.0 million, a 3.46% decrease, with the full-year FY2025 number at $917.4 million, up 440.06% from a year prior.
  • Shares Repurchased hit $4.5 million in Q3 2025 for Medpace Holdings, down from $518.5 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $518.5 million in Q2 2025 to a low of $4.5 million in Q3 2025.
  • Median Shares Repurchased over the past 5 years was $120.1 million (2023), compared with a mean of $192.6 million.
  • Biggest five-year swings in Shares Repurchased: soared 638.16% in 2021 and later crashed 93.62% in 2023.
  • Medpace Holdings' Shares Repurchased stood at $5.9 million in 2021, then surged by 699.69% to $47.2 million in 2022, then crashed by 49.35% to $23.9 million in 2023, then soared by 610.74% to $169.9 million in 2024, then crashed by 97.35% to $4.5 million in 2025.
  • The last three reported values for Shares Repurchased were $4.5 million (Q3 2025), $518.5 million (Q2 2025), and $371.9 million (Q1 2025) per Business Quant data.